Display Settings:


Send to:

Choose Destination
See comment in PubMed Commons below
Vet J. 2010 Jul;185(1):58-61. doi: 10.1016/j.tvjl.2010.04.014.

The use of adrenocorticotrophic hormone as a potential biomarker of pituitary pars intermedia dysfunction in horses.

Author information

  • 1Pegasus Equine Diagnostics Ltd., BioCity Nottingham, Nottingham NG1 1GF, UK.


Elevated concentrations of plasma adrenocorticotrophic hormone (ACTH) in horses with pituitary disturbances are often associated with dysfunction of the pituitary's pars intermedia. The majority of such animals exhibit an increased susceptibility to laminitis, particularly during the autumn. The 24h plasma ACTH profiles of horses with pituitary pars intermedia dysfunction (PPID), and those of matched controls, were determined in March, June, September and December. Differences in ACTH concentrations between the groups were significant (P<0.0001), regardless of photoperiod, and persisted throughout the 24h cycle in all seasons. ACTH concentrations were significantly higher in September and December than in March and June in both groups of animals. Cosinor analysis of the data indicated that the amplitude of changes was season-independent but higher (P=0.0441) in PPID horses and that a significant interaction (P=0.0096) existed between body condition (control versus PPID) and season of peak ACTH response. There were significant, but opposite, phase-shift differences in June and September. These results suggest that ACTH has a role as a biomarker of equine PPID providing that appropriate 'cut-off' values are used at different times of the year.

Copyright 2010. Published by Elsevier Ltd.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk